Cancer Trials in Houston, United States
Conditions / Cancer / Houston, United States
Research into Cancer spans multiple therapeutic approaches and trial phases.
210 total trials for this combination
Showing top 10 of 210 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04981119 | Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing | RECRUITING | — |
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | RECRUITING | — |
| NCT00858364 | Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | TERMINATED | PHASE3 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT03668223 | The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer | COMPLETED | NA |
| NCT06533059 | A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | RECRUITING | PHASE1 |
| NCT05736731 | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT02391480 | A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer | COMPLETED | PHASE1 |
| NCT05500508 | Oral AMXT 1501 Dicaprate in Combination With IV DFMO | TERMINATED | PHASE1/PHASE2 |